A Novel Phase 2a Study Design To Investigate Drug-Drug Interactions Between Escalating Doses of At2220 (Duvoglustat Hydrochloride) and Acid Alpha-Glucosidase in Subjects With Pompe Disease Academic Article
Identity
Web of Science ID
- 000310103600154
Digital Object Identifier (DOI)
Additional Document Info
start page
- 852
volume
- 22